Photo from Prithviraj Bose/X
Jun 16, 2024, 12:58
Prithviraj Bose: Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS
Prithviraj Bose, Professor of Leukemia at MD Anderson Cancer Centre, shared on X:
“Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS also with ropeg in PROUD/CONTI-PV as with rux in MAJIC-PV.”
Source: Prithviraj Bose/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 11, 2024, 13:56
Sep 11, 2024, 13:54
Sep 11, 2024, 13:05
Sep 11, 2024, 11:11
Sep 11, 2024, 10:55
Sep 11, 2024, 10:52